A dual-modality SPECT/MR probe of<sup>99m</sup>Tc-Transferrin-DTPA-Gd for the detection of tumor transferrin receptor expression<em>in vivo</em>

顾丙新; 孙玉云; 杨忠毅; 罗建民; 张建平; 章英剑

doi:10.19401/j.cnki.1007-3639.2019.02.004

您当前的位置：

首页 >

文章列表页 >

A dual-modality SPECT/MR probe of^99mTc-Transferrin-DTPA-Gd for the detection of tumor transferrin receptor expressionin vivo

更新时间：2026-01-27

- A dual-modality SPECT/MR probe of^99mTc-Transferrin-DTPA-Gd for the detection of tumor transferrin receptor expressionin vivo
- China Oncology Vol. 29, Issue 2, Pages: 119-124(2019)
- 作者机构：
  
  1. 复旦大学附属肿瘤医院核医学科，复旦大学上海医学院肿瘤学系,上海,200032
  2. 复旦大学生物医学影像研究中心,上海,200032
  3. 上海分子影像探针工程技术研究中心,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2019.02.004
  CLC： R445.2;R730.4
- Published Online：25 March 2019，
  
  Published：25 March 2019
- 稿件说明：
移动端阅览
顾丙新，孙玉云，杨忠毅，罗建民，张建平，章英剑.

顾丙新, 孙玉云, 杨忠毅, et al. A dual-modality SPECT/MR probe of^99mTc-Transferrin-DTPA-Gd for the detection of tumor transferrin receptor expressionin vivo[J]. China Oncology, 2019, 29(2): 119-124.
顾丙新，孙玉云，杨忠毅，罗建民，张建平，章英剑. DOI： 10.19401/j.cnki.1007-3639.2019.02.004.

顾丙新, 孙玉云, 杨忠毅, et al. A dual-modality SPECT/MR probe of^99mTc-Transferrin-DTPA-Gd for the detection of tumor transferrin receptor expressionin vivo[J]. China Oncology, 2019, 29(2): 119-124. DOI： 10.19401/j.cnki.1007-3639.2019.02.004.

摘要

背景与目的：转铁蛋白（Holo-Transferrin，Tf）受体（transferrin receptor，TfR）广泛存在于恶性肿瘤细胞膜表面，并被认为是抗肿瘤治疗的靶点。本研究旨在探讨

99m

Tc-Tf-DTPA-Gd在体、无创性检测多种人源性肿瘤TfR表达情况的可行性。方法：制作10种人肿瘤细胞的BALB/c裸小鼠移植瘤模型；经荷瘤鼠尾静脉注射

99m

Tc-Tf-DTPA-Gd或Tf-DTPA-Gd 4 h后行单光子发射计算机断层摄影术（single-photon emission computed tomography，SPECT）/计算机断层摄影术（computed tomography，CT）或磁共振成像（magnetic resonance imaging，MRI）检查，勾画感兴趣区（region of interest，ROI），计算靶本比值即靶区/肌肉组织（target-to-muscle ratios，T/M）或相对信号增强值（relative signal enhancement，rSE）；显像结束后取肿瘤组织行H-E染色及免疫组织化学染色，采用H-score法评估10种肿瘤表达TfR水平。选用两样本t检验及Spearman分析数据。结果：10种移植瘤模型均可用于成像。注射双模态探针4 h后，有9种肿瘤摄取

99m

Tc-Tf-DTPA-Gd，其中胶质瘤细胞U87的T/M值最高，乳腺癌细胞MDA-MB-468也有较高的T/M值；而前列腺癌细胞PC-3肿瘤几乎不摄取，T/M值接近1，与MDA-MB-468 T/M值相比差异有统计学意义（t=6.919，P=0.002）。MRI显示，MDA-MB-468肿瘤强化明显，rSE达（154.88±8.71）%，而PC-3肿瘤为（111.31±3.46）%，差异有统计学意义（t=8.441，P=0.001）。PC-3肿瘤几乎不表达TfR，其余9种肿瘤均不同程度地表达TfR。TfR免疫组织化学检测结果与探针的T/M值呈明显的正相关（相关系数为r=0.915，P0.001）。结论：

99m

Tc-Tf-DTPA-Gd可在体、无创性反映肿瘤表达TfR受体情况。

Abstract

Background and purpose: Transferrin (Tf) receptor (TfR) is expressed broadly in malignant cells

and has been developed as a target for anti-tumor therapy. This study aimed to investigate the feasibility of

99m

Tc-Tf-DTPA-Gd noninvasively detecting tumor TfR expression in vivo. Methods: We established 10 xenograft tumor models with mice.

99m

Tc-Tf-DTPA-Gd and Tf-DTPA-Gd were injected into mice via tail vein respectively

and 4 hours later single-photon emission computed tomography (SPECT)/ computed tomography (CT) and magnetic resonance imaging (MRI) were acquired. The values of target-to-muscle ratios (T/M) and relative signal enhancement (rSE) were calculated by drawing regions of interest (ROI) in tumors. H-E staining and immunohistochemistry detection were applied when imaging was completed. Statistical analysis was performed using two-sample t test. Results: The tumors were clearly visible except PC-3 after administration with

99m

Tc-Tf-DTPA-Gd. The value of T/M between MDA-MB-468 and PC-3 showed statistically significant difference (t=6.919

P=0.002). In MRI experiment

the tumor of MDAMB-468 was enhanced distinctly

while the signal of PC-3 tumor approximated the pre-injection. The rSE between MDA-MB-468 and PC-3 also showed statistically significant difference (t=8.441

P=0.001). Immunohistochemistry staining showed 9 of these xenograft tumor models expressing TfR in various degree rather than PC-3 tumor. Conclusion:

99m

Tc-Tf-DTPA-Gd could serve as an ideal probe for detecting tumor TfR expression in vivo noninvasively.

关键词

Keywords

references

Views

1889

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: progress in ultrasound, CT, MRI and ablation of thyroid nodules and differentiated thyroid cancer

Research progress and prospects of MRI in predicting lymph node status in breast cancer

The unique value and controversy of nuclear medicine molecular imaging in the evaluation of radioiodine-refractory differentiated thyroid cancer

Magnetic resonance imaging for distinguishing gastric-type endocervical adenocarcinoma from lobular endocervical glandular hyperplasia

Research progress on the correlation between imaging features and the molecular subtype, histopathology, clinical prognosis of ductal carcinoma in situ of the breast

Related Author

Ruyu LIU

Chenyi WANG

Bo ZHANG

Zihan ZHAI

Sheng CHEN

Renfei WANG

Gaixia LU

Fenghua MA

Related Institution

Japan Friendship Hospital (Institute of Clinical Medical Sciences), Peking Union Medical College, Chinese Academy of Medical Sciences,, China

Department of Ultrasound, China-Japan Friendship Hospital

National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Center of Respiratory Medicine, China-Japan Friendship Hospital

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

Department of Nuclear Medicine, Shanghai Tenth People’s Hospital, Tongji University School of Medicine

AI问答

⁰

A dual-modality SPECT/MR probe of99mTc-Transferrin-DTPA-Gd for the detection of tumor transferrin receptor expressionin vivo

DOI：10.19401/j.cnki.1007-3639.2019.02.004

摘要

Abstract

关键词

Keywords

references

A dual-modality SPECT/MR probe of^99mTc-Transferrin-DTPA-Gd for the detection of tumor transferrin receptor expressionin vivo